ATE360621T1 - Substituierte benzimidazole als nicht-nucleosid- inhibitoren von reverser transcriptase - Google Patents

Substituierte benzimidazole als nicht-nucleosid- inhibitoren von reverser transcriptase

Info

Publication number
ATE360621T1
ATE360621T1 AT00959441T AT00959441T ATE360621T1 AT E360621 T1 ATE360621 T1 AT E360621T1 AT 00959441 T AT00959441 T AT 00959441T AT 00959441 T AT00959441 T AT 00959441T AT E360621 T1 ATE360621 T1 AT E360621T1
Authority
AT
Austria
Prior art keywords
nucleoside inhibitors
substituted benzimidazoles
reverser
transcriptase
reverser transcriptase
Prior art date
Application number
AT00959441T
Other languages
English (en)
Inventor
Christopher J Michejda
Marshall Morningstar
Thomas Roth
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE360621T1 publication Critical patent/ATE360621T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00959441T 1999-08-26 2000-08-25 Substituierte benzimidazole als nicht-nucleosid- inhibitoren von reverser transcriptase ATE360621T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38017199A 1999-08-26 1999-08-26

Publications (1)

Publication Number Publication Date
ATE360621T1 true ATE360621T1 (de) 2007-05-15

Family

ID=23500167

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00959441T ATE360621T1 (de) 1999-08-26 2000-08-25 Substituierte benzimidazole als nicht-nucleosid- inhibitoren von reverser transcriptase

Country Status (5)

Country Link
EP (1) EP1210336B1 (de)
AT (1) ATE360621T1 (de)
AU (1) AU7076600A (de)
DE (1) DE60034578D1 (de)
WO (1) WO2001014343A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR063311A1 (es) 2006-10-18 2009-01-21 Novartis Ag Compuestos organicos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0963371B1 (de) * 1997-02-25 2003-05-02 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Substituierte benzimidazole als nicht-nucleoside reverse transcriptase inhibitore

Also Published As

Publication number Publication date
AU7076600A (en) 2001-03-19
DE60034578D1 (de) 2007-06-06
EP1210336A1 (de) 2002-06-05
EP1210336B1 (de) 2007-04-25
WO2001014343A1 (en) 2001-03-01

Similar Documents

Publication Publication Date Title
DE69814049D1 (de) Substituierte benzimidazole als nicht-nucleoside reverse transcriptase inhibitore
MY142948A (en) Benzophenones as inhibitors of reverse transcriptase
BR0309557A (pt) Inibidores da transcriptase reversa não nucleosìdeos
CY1110690T1 (el) Ενωσεις 4-οξοκινολινης και χρησιμοποιηση αυτων ως αναστολεις της ενσωματασης του hiv
ES2178036T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que le contienen.
DE60022523D1 (de) Aminopiperidinderivate als antibakterielles arzneimittel
ATE373005T1 (de) Thienopyrrole als antivirale mittel
ATE209931T1 (de) Hämoglobin-hydroxyethylstärke-konjugate als sauerstoff-transport-mittel
YU53093A (sh) Benzoksazinoni kao inhibitori hiv reverzne transkriptaze
ES2174921T3 (es) Inhibidores de la proteasa del vih.
NO962000L (no) Prolegemidler av en inhibitor av HIV-protease
ATE360621T1 (de) Substituierte benzimidazole als nicht-nucleosid- inhibitoren von reverser transcriptase
MX9705916A (es) Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc.
BR0213741A (pt) composto e composição antiretrovirais
UY26329A1 (es) Antagonistas de los receptores de vitronectina
NO20015398L (no) Endoparasitticidisk synergistisk kombinasjon inneholdende cykliske depsipeptider og piperaziner
PT1411956E (pt) Utilizacao de polissacaridos sobre-sulfatados como inibidores de vih
BR0009102A (pt) Compostos tiofenoetil tiouréia e uso no tratamento do hiv
SE9402241D0 (sv) Inhibitor
NO20024522D0 (no) Sammensetninger med anti-hiv-aktivitet
DK1368478T3 (da) Polypeptid, der fremkalder HIV-neutraliserende antistoffer
TR200201141T2 (tr) 2-Amino-3,4-dihidro-kinazolinlerin bir ilacın üretiminde kullanımı
ES2190456T3 (es) Combinacion de inhibidores de la proteasa del vih.
DK1220844T3 (da) Arylsulfonamid-substituerede benzimidazolderivater og deres anvendelse som tryptase-inhibitorer
DK1075476T3 (da) Hidtil ukendte benzimidazoler og benzoxazoler

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties